Evidence map›Paper›PMID 41813840›Full record

ArticleScientific reports2026

Knockdown of RNA editing proteins reshapes the HepaRG transcriptome and pharmacogene expression.

Joseph M Collins, Fahong Yu, Yanping Zhang, Danxin Wang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joseph M CollinsDepartment of Pharmacotherapy and Translational Research, College of Pharmacy, Center for Pharmacogenomics, University of Florida, 1345 Center Drive MSB PG-29, 32610, Gainesville, USA.
Fahong YuBioinformatics at Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, Florida 32610, USA.
Yanping ZhangGene expression & genotyping at Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, FL, 32610, USA.
Danxin WangDepartment of Pharmacotherapy and Translational Research, College of Pharmacy, Center for Pharmacogenomics, University of Florida, 1345 Center Drive MSB PG-29, 32610, Gainesville, USA. Danxin.wang@cop.ufl.edu.

Funding

Expression genetics of pharmacogenesR35GM140845 · NIGMS · UNIVERSITY OF FLORIDA · PI Danxin Wang · 2021 to 2026
$2.2M
NIGMS NIH HHS R35 GM 140845
6 · The paper itself

Abstract

The RNA-editing proteins ADAR and ADARB1 regulate gene expression through both editing-dependent and editing-independent mechanisms. RNA-Seq analysis of HepaRG cells after knocking down (KD) either protein caused widespread transcriptomic changes, including nearly 1,000 pharmacogenes that were either differentially expressed or alternatively spliced, with isoform switches observed in HNF4A and CYP2C9. These effects were editing-independent, and the two treatments primarily affected distinct gene sets, with ADAR KD having broader effects than ADARB1 KD. Because ADAR KD triggers a type I interferon response, we compared siADAR and IFNα treatments. Although both activated interferon signaling, their transcriptional profiles differed markedly. Despite this, 70% of siADAR-responsive genes were rescued by BX795, an inhibitor of the interferon pathway. Therefore, many of siADAR’s effects are likely due to the activation of immune pathways. Overall, our findings indicated that the ADARs maintain hepatic homeostasis and regulate numerous pharmacogenes, especially those involved in drug metabolism and disposition.

Indexed as

Adenosine DeaminaseRNA-Binding ProteinsRNA EditingTranscriptomeAlternative SplicingCell LineCytochrome P-450 CYP2C9Gene Expression ProfilingGene Expression RegulationGene Knockdown TechniquesHepatocyte Nuclear Factor 4HumansInterferon-alphaInterferon Type ISignal TransductionADARB1 protein, humanADAR protein, humanAdenosine DeaminaseCytochrome P-450 CYP2C9Hepatocyte Nuclear Factor 4HNF4A protein, humanInterferon-alphaInterferon Type IRNA-Binding ProteinsADARADARB1gene expressionRNA editingsplicingtype I interferon response

Identifiers

PMID41813840
PMCPMC13100024

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.